Andrew Dudum is the CEO and co-founder of Hims & Hers Health, Inc., a company that provides accessible health and wellness products. With a background in entrepreneurship, he earned his Sociology degree from UCLA. Dudum leads a company that focuses...

Andrew Dudum is the CEO and co-founder of Hims & Hers Health, Inc., a company that provides accessible health and wellness products. With a background in entrepreneurship, he earned his Sociology degree from UCLA. Dudum leads a company that focuses on breaking down barriers to healthcare, especially for younger generations. He is an active player in the tech startup world, having been part of various successful startups before Hims & Hers. Notably, he holds significant ownership, with over 18 million shares, representing 9.1% of the company, which shows his commitment. In 2023, Dudum had a total compensation of about $14.4 million, driven largely by performance bonuses tied to revenue growth and profits. Under his leadership, the company reported impressive revenue increases and an expanding subscriber base. He reflects a new wave of leaders who prioritize innovation and health accessibility.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

H

Andrew Dudum

Founder and CEO of Hims & Hers Health

Education

Bachelor's degree in Sociology from the University of California, Los Angeles

Field of Expertise

Business & Management - Entrepreneurship

Sector of Economy

Consumer Defensive

Born

January 1, 1989 - 36 years ago

CEO of Hims & Hers Health for

8 years 3 months (Jan 2017 - Present)

Previous Experience

Co-Founder of Hims & Hers Health, Inc.

Rivals

Competitors/colleagues of Andrew Dudum

Holdings

See how much did Andrew Dudum make over time.

Andrew Dudum's stake in Hims & Hers Health is quite substantial. He owns around 18.8 million shares of Class A common stock, approximately 9.1% of the company. This ownership has fluctuated since the company went public, reflecting his strong belief...

Andrew Dudum's stake in Hims & Hers Health is quite substantial. He owns around 18.8 million shares of Class A common stock, approximately 9.1% of the company. This ownership has fluctuated since the company went public, reflecting his strong belief in its mission and future. As of now, his voting power is even more impressive, with total voting power of about 89.2% because he also controls Class V shares. His net worth from these holdings reflects his commitment to the company’s growth and success. Dudum's wealth is significantly tied to Hims & Hers' performance, exemplified by recent stock prices and the company's trajectory in the health market.

Mar 18, 2025

H

shares

HIMS @ $31.49

Total Stock Sold

$153.88M

HIMS

$153.88M

7,006,045 HIMS shares

What if they kept their stock?

If Andrew Dudum didn't sell their stock, today they would have:
Extra HIMS7,006,045 shares worth $108.10M.
This is -29.75% and $45.77M less than what they got when they sold the stock.

Charitable Transactions

HIMS

13,715,875 shares

HIMS

Recent Charitable Transactions

HIMS

4,438,794 shares

HIMS

Dec 15, 2022

Charity

HIMS

1,402,312 shares

HIMS

Sep 15, 2022

Charity

HIMS

5,000,000 shares

HIMS

Jan 20, 2022

Charity

HIMS

2,874,769 shares

HIMS

Sep 22, 2021

Charity

Insider Trading

See recent insider trades of Andrew Dudum.

HIMS

$10.31M

HIMS at $58.67/share

Feb 18, 2025

Sale

HIMS

$14.09M

HIMS at $35.22/share

Jan 31, 2025

Sale

HIMS

$3.26M

HIMS at $30.08/share

Jan 23, 2025

Sale

HIMS

$1.75M

HIMS at $30.04/share

Jan 21, 2025

Sale

HIMS

$9.12M

HIMS at $27.16/share

Jan 16, 2025

Sale

HIMS

$24.60M

HIMS at $30.01/share

Dec 13, 2024

Sale

HIMS

$24.60M

HIMS at $30.01/share

Dec 13, 2024

Sale

HIMS

$4.47M

HIMS at $33.38/share

Dec 2, 2024

Sale

HIMS

$756.80K

HIMS at $16.54/share

Sep 20, 2024

Sale

HIMS

$4.84M

HIMS at $14.53/share

Sep 3, 2024

Sale

Compensation History

See how much did Andrew Dudum make over time.

In 2023, Andrew Dudum's total compensation was approximately $14.4 million. This includes a base salary of $625,000 and a performance bonus of about $1.1 million. His compensation package is heavily tied to the company's performance, with bonuses linked to hitting financial targets like revenue and EBITDA. Dudum also received sizable stock awards, including 567,144 RSUs and options that promise substantial value as the company grows. The structure of his pay reflects a trend in modern executive compensation, where a significant portion is at risk and tied directly to the success and profitability of the business.

Year

2023

Total Compensation

$8.48M

Salary

$625.00K

Board Justification

The compensation philosophy aims to attract and retain top talent while aligning executive compensation with company performance and shareholder interests through a mix of fixed and performance-based pay.

Bonus

$1.14M

Board Justification

The target annual incentive bonus opportunity for the CEO was set at 100% of his annual base salary, with actual bonuses based on achieving 183% of the target due to exceeding performance metrics for revenue and Adjusted EBITDA.

Other

$167.60K

Board Justification

This includes a $3,000 Company match for participation in the 401(k) Plan and reimbursement for a home security system.

Restricted Stock

$6.54M(567.14K RSU)

Board Justification

The RSU awards granted to the CEO vest quarterly over four years, with the first vesting date on June 15, 2023, subject to continuous service.

Performance Metrics

The performance metrics for determining the CEO's compensation included revenue and Adjusted EBITDA targets.